Study Name:
Phase II Study of Induction (Daunorubicin/Cytarabine) and Consolidation (High-Dose Cytarabine) Chemotherapy Plus Dasatinib (NSC #732517, IND #73969) and Continuation Therapy With Dasatinib Alone in Newly Diagnosed Patients With Core Binding Factor Acute Myeloid Leukemia (AML).
|
|
Purpose:
This phase II trial is studying the side effects and how well giving combination chemotherapy together with dasatinib works in treating patients with newly diagnosed acute myeloid leukemia.
|
|
Study Type: Treatment
Protocol: UIC 2011-0863 CALGB 10801
|
|
For study details, click here.
Internal users only: click here for protocol details and forms
|
Study Name:
Assessment of Novel Molecular Markers in Acute Myeloid Leukemia.
|
|
Purpose:
This research study is looking at tissue and blood samples from patients with acute myeloid leukemia.
|
|
Study Type: Observational
Protocol: UIC 2010-0368 CALGB 20202
|
|
For study details, click here.
Internal users only: click here for protocol details and forms
|
Study Name:
Molecular Genetic Features of Acute Lymphoblastic Leukemia
|
|
Purpose:
Diagnostic study of genetic markers in adult patients who have acute lymphoblastic leukemia or acute promyelocytic leukemia.
|
|
Study Type: Diagnostic
Protocol: UIC 2004-0712 CALGB 9862
|
|
For study details, click here.
Internal users only: click here for protocol details and forms
|
Study Name:
Cytogenetic Studies For Previously Untreated AML, ALL or MDS Patients (Companion To CALGB Treatment Studies For Previously Untreated AML, ALL Or MDS Patients).
|
|
Purpose:
This diagnostic trial is studying genetic differences in patients with treated and untreated acute myeloid leukemia, acute lymphoblastic leukemia, myelodysplastic syndromes, or multiple myeloma.
|
|
Study Type: Diagnostic
Protocol: UIC 1996-0603 CALGB 8461
|
|
For study details, click here.
Internal users only: click here for protocol details and forms
|
Study Name:
The CALGB Leukemia Tissue Bank
|
|
Purpose:
This laboratory study is collecting and storing blood, bone marrow, and other samples from patients with acute leukemia, chronic leukemia, or myelodysplastic syndromes.
|
|
Study Type: Observational
Protocol: UIC 1996-0806 CALGB 9665
|
|
For study details, click here.
Internal users only: click here for protocol details and forms
|
Back to Oncology Clinical Trials Homepage